Lepu Biopharma (02157) receives shareholding increase of 1.05 million H shares by Chairman and Executive Director Pu Zhongjie

Zhitong Finance APP News, Lepu Biopharma (02157) announced that the Board has received notification from Dr. Pu Zhongjie (Dr. Pu, Chairman and Executive Director, and controlling shareholder of the Company) that on October 27, 2026, he purchased a total of 1.05 million H shares of the Company (H Shares) through the Shanghai-Hong Kong Stock Connect on the open market using his own funds at an average price of approximately RMB 3.04 per H share (approximately HK$3.55), representing approximately 0.06% of the total number of issued shares of the Company as at the date of this announcement.